Articles and Blogs

In an unusual move, the U.S. Department of Health and Human Services (“HHS”), rather than the U.S. Food and Drug Administration (“FDA”), announced the availability of an interim enforcement policy in the Federal Register on October 30, 2026 (91 Fed. Reg. 68,526), addressing compounding with six peptide bulk drug substances. The policy provides limited... READ MORE